Prelude therapeutics reports full year 2021 financial results

Significant progress achieved in 2021: pipeline now includes six internally discovered small molecule compounds targeting clinically validated pathways in cancers with underserved patients

PRLD Ratings Summary

PRLD Quant Ranking